-
My Account
In App
My Account
| Particulars | This Scheme | Category |
|---|---|---|
| No. of Stocks | 20 | 76.88 |
| Top 5 Stock Weight | 58.33% | 36.95% |
| Top 10 Stock Weight | 78.96% | 54.07% |
| Top 3 Sector Weight | % | 34.19% |
| Particulars | This Scheme | Category |
|---|---|---|
| Average mcap (Cr) | 40550.96 | 112157.02 |
| Holdings in large cap stocks | 53.22% | 50.59% |
| Holdings in mid cap stocks | 19.74% | 15.75% |
| Holdings in small cap stocks | 2.61% | 8.6% |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 2268.9 | 22.18% | 0.00% | 25.53% (Apr 2025) | 21.62% (Sep 2025) | 13.42 L | -1.12 k |
| # Divis Laboratories Ltd. | Pharmaceuticals | 1089.9 | 10.65% | 0.00% | 11.02% (May 2025) | 9.3% (Sep 2025) | 1.62 L | -0.14 k |
| # Cipla Ltd. | Pharmaceuticals | 1075.3 | 10.51% | 0.00% | 11.43% (Aug 2025) | 10.21% (Dec 2024) | 7.16 L | -0.60 k |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 929.1 | 9.08% | 0.00% | 10.29% (Dec 2024) | 9.29% (Mar 2025) | 7.76 L | -0.65 k |
| # Lupin Ltd. | Pharmaceuticals | 604.9 | 5.91% | 0.00% | 6.9% (Dec 2024) | 5.7% (Jul 2025) | 3.08 L | -0.26 k |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 474.2 | 4.64% | 0.00% | 4.85% (Sep 2025) | 3.71% (Oct 2024) | 1.33 L | -0.11 k |
| # Laurus Labs Ltd. | Pharmaceuticals | 471.8 | 4.61% | 0.00% | 4.29% (Aug 2025) | 2.43% (Oct 2024) | 4.95 L | -0.41 k |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 405.6 | 3.97% | 0.00% | 4.9% (Oct 2024) | 3.68% (Aug 2025) | 3.56 L | -0.30 k |
| # Alkem Laboratories Ltd. | Pharmaceuticals | 394.8 | 3.86% | 0.00% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 71.71 k | -60.00 |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 362.7 | 3.55% | 0.00% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 1.92 L | -0.17 k |
| Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 99.97 | 2268.9 | 22.18% | 0.00% | 25.53% (Apr 2025) | 21.62% (Sep 2025) | 13.42 L | -1.12 k | Large Cap | 53.22 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 99.97 | 1089.9 | 10.65% | 0.00% | 11.02% (May 2025) | 9.3% (Sep 2025) | 1.62 L | -0.14 k | Large Cap | 53.22 |
| # Cipla Ltd. | Pharmaceuticals | 99.97 | 1075.3 | 10.51% | 0.00% | 11.43% (Aug 2025) | 10.21% (Dec 2024) | 7.16 L | -0.60 k | Large Cap | 53.22 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 99.97 | 929.1 | 9.08% | 0.00% | 10.29% (Dec 2024) | 9.29% (Mar 2025) | 7.76 L | -0.65 k | Other | 24.4 |
| # Lupin Ltd. | Pharmaceuticals | 99.97 | 604.9 | 5.91% | 0.00% | 6.9% (Dec 2024) | 5.7% (Jul 2025) | 3.08 L | -0.26 k | Large Cap | 53.22 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 99.97 | 474.2 | 4.64% | 0.00% | 4.85% (Sep 2025) | 3.71% (Oct 2024) | 1.33 L | -0.11 k | Mid Cap | 19.74 |
| # Laurus Labs Ltd. | Pharmaceuticals | 99.97 | 471.8 | 4.61% | 0.00% | 4.29% (Aug 2025) | 2.43% (Oct 2024) | 4.95 L | -0.41 k | Other | 24.4 |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 99.97 | 405.6 | 3.97% | 0.00% | 4.9% (Oct 2024) | 3.68% (Aug 2025) | 3.56 L | -0.30 k | Large Cap | 53.22 |
| # Alkem Laboratories Ltd. | Pharmaceuticals | 99.97 | 394.8 | 3.86% | 0.00% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 71.71 k | -60.00 | Mid Cap | 19.74 |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 99.97 | 362.7 | 3.55% | 0.00% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 1.92 L | -0.17 k | Mid Cap | 19.74 |
| # Mankind Pharma Ltd. | Pharmaceuticals | 99.97 | 343.3 | 3.36% | 0.00% | 3.66% (May 2025) | 3.1% (Nov 2024) | 1.44 L | -0.13 k | Other | 24.4 |
| # Zydus Lifesciences Ltd. | Pharmaceuticals | 99.97 | 310 | 3.03% | 0.00% | 3.22% (Jan 2025) | 2.87% (Apr 2025) | 3.18 L | -0.27 k | Mid Cap | 19.74 |
| # Biocon Ltd. | Pharmaceuticals | 99.97 | 284.6 | 2.78% | 0.00% | 2.87% (Jul 2025) | 1.78% (Oct 2024) | 7.65 L | -0.64 k | Mid Cap | 19.74 |
| # Ipca Laboratories Ltd. | Pharmaceuticals | 99.97 | 225 | 2.20% | 0.00% | 2.79% (Dec 2024) | 2.39% (Sep 2025) | 1.77 L | -0.15 k | Other | 24.4 |
| # Gland Pharma Ltd. | Pharmaceuticals | 99.97 | 195.5 | 1.91% | 0.00% | 2.04% (Sep 2025) | 1.44% (Apr 2025) | 1.01 L | -85.00 | Other | 24.4 |
| # Abbott India Ltd. | Pharmaceuticals | 99.97 | 192.6 | 1.88% | 0.00% | 2.35% (Jun 2025) | 1.8% (Jan 2025) | 6.64 k | -5.00 | Mid Cap | 19.74 |
| # J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 99.97 | 174.4 | 1.70% | 0.00% | 1.79% (Sep 2025) | 1.49% (Apr 2025) | 1.04 L | -85.00 | Other | 24.4 |
| # Piramal Pharma Ltd. | Pharmaceuticals | 99.97 | 157.1 | 1.54% | 0.00% | 1.52% (Sep 2025) | 0% (Oct 2024) | 7.87 L | -0.66 k | Other | 24.4 |
| # Wockhardt Ltd. | Pharmaceuticals | 99.97 | 134.8 | 1.32% | 0.00% | 1.61% (Sep 2025) | 0% (Oct 2024) | 1.05 L | -90.00 | Small Cap | 2.61 |
| # Ajanta Pharma Limited | Pharmaceuticals | 99.97 | 132.2 | 1.29% | 0.00% | 1.63% (Nov 2024) | 1.3% (Sep 2025) | 53.62 k | -45.00 | Small Cap | 2.61 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No new entrants in the portfolio in the last month. | ||||||||
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No complete exits in the portfolio in the last month. | ||||||||
| Stock | Oct 2025 | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 22.18% | 21.62% | 21.98% | 22.48% | 22.82% | 23.74% | 25.53% | 24.90% | 24.69% | 24.97% | 24.73% | 24.69% | 25.08% |
| Cipla Ltd. | 10.51% | 10.88% | 11.43% | 10.68% | 10.70% | 10.82% | 11.27% | 10.80% | 11.11% | 10.78% | 10.21% | 10.83% | 10.71% |
| Divis Laboratories Ltd. | 10.65% | 9.30% | 9.95% | 10.23% | 10.92% | 11.02% | 9.99% | 9.76% | 9.99% | 9.40% | 9.41% | 10.06% | 9.39% |
| Dr. Reddys Laboratories Ltd. | 9.08% | 9.59% | 9.81% | 9.45% | 9.87% | 10.02% | 9.33% | 9.29% | 9.77% | 9.85% | 10.29% | 9.42% | 9.76% |
| Lupin Ltd. | 5.91% | 5.95% | 5.86% | 5.70% | 5.92% | 6.21% | 6.54% | 6.52% | 6.59% | 6.65% | 6.90% | 6.35% | 6.62% |
| Torrent Pharmaceuticals Ltd. | 4.64% | 4.85% | 4.76% | 4.78% | 4.50% | 4.36% | 4.49% | 4.49% | 3.97% | 4.07% | 3.83% | 3.94% | 3.71% |
| Aurobindo Pharma Ltd. | 3.97% | 3.90% | 3.68% | 3.89% | 4.01% | 4.21% | 4.44% | 4.32% | 4.24% | 4.34% | 4.53% | 4.53% | 4.90% |
| Alkem Laboratories Ltd. | 3.86% | 3.93% | 3.66% | 3.31% | 3.36% | 3.56% | 3.51% | 3.45% | 3.54% | 3.57% | 3.63% | 3.78% | 3.79% |
| Mankind Pharma Ltd. | 3.36% | 3.54% | 3.57% | 3.54% | 3.31% | 3.66% | 3.60% | 3.64% | 3.41% | 3.35% | 3.63% | 3.10% | 3.16% |
| Laurus Labs Ltd. | 4.61% | 4.21% | 4.29% | 4.18% | 3.58% | 3.13% | 3.05% | 3.20% | 2.98% | 3.05% | 2.88% | 2.86% | 2.43% |
| Glenmark Pharmaceuticals Ltd. | 3.55% | 3.78% | 3.70% | 3.93% | 3.34% | 2.88% | 2.69% | 3.09% | 2.76% | 2.90% | 2.94% | 2.95% | 3.20% |
| Zydus Lifesciences Ltd. | 3.03% | 3.16% | 3.13% | 2.96% | 3.12% | 3.05% | 2.87% | 2.95% | 3.14% | 3.22% | 2.95% | 3.10% | 3.14% |
| Ipca Laboratories Ltd. | 2.20% | 2.39% | 2.46% | 2.50% | 2.44% | 2.60% | 2.52% | 2.78% | 2.64% | 2.59% | 2.79% | 2.69% | 2.71% |
| Biocon Ltd. | 2.78% | 2.64% | 2.68% | 2.87% | 2.70% | 1.99% | 1.87% | 2.05% | 1.95% | 2.16% | 1.99% | 2.11% | 1.78% |
| Abbott India Ltd. | 1.88% | 1.97% | 2.09% | 2.19% | 2.35% | 2.08% | 2.02% | 2.13% | 2.27% | 1.80% | 1.88% | 1.85% | 1.90% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.38% |
| Margin | Margin | 0.00% |
| Net Receivables | Net Receivables | -0.35% |
Let your Money Earn More, Safely and Smartly with a Secured Bond 9.41% INDIA INFRASTRUCTURE FINANCE COMPANY LIMITED 2037 ✔️ Coupon: 9.41% "✔️ Rating: CARE AAA Stable" ✔️ Tenor: 11y 8m (Maturity: 27/Jul/2037)** Secured Bond | PSU Bond | High Return Bond | Listed A secured PSU bond offering the ideal mix of attractive returns and solid rating stability. Perfect for investors who prefer disciplined growth over market swings. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dUJHdFp3PT0=/941-india-infrastructure-finance-company-limited-2037?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more
Posted by : The Fixed Income
Repost this message
Let your Money Earn More, Safely and Smartly with a Secured Bond 9.41% INDIA INFRASTRUCTURE FINANCE COMPANY LIMITED 2037 ✔️ Coupon: 9.41% "✔️ Rating: CARE AAA Stable" ✔️ Tenor: 11y 8m (Maturity: 27/Jul/2037)** Secured Bond | PSU Bond | High Return Bond | Listed A secured PSU bond offering the ideal mix of attractive returns and solid rating stability. Perfect for investors who prefer disciplined growth over market swings. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dUJHdFp3PT0=/941-india-infrastructure-finance-company-limited-2037?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
need your suggestion for sbi psu fund direct growth stay or switch View more
Posted by : shravanashok
Dividend last declared by SBI Long Term Equity Fund - regular Plan -IDCW was in the year 2022. Is there any specific reason given by fund managers for non declaration of dividend. Please let me know. View more
Posted by : ravisistla
Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more
Posted by : sunny85deol
